Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026)
Repligen (RGEN) posted quarterly Non-Current Deferred Tax Liability of $16.8 million for Q2 2026, down 28.07% year-over-year from $23.3 million in Q2 2025, and up 11.72% quarter-over-quarter from $15.0 million in Q1 2026.
Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $16.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 28.07% year-over-year to $16.8 million; the TTM figure through Jun 2026 stood at $16.8 million (down 28.07% YoY), while the FY2025 annual figure was $22.5 million, down 1.23% from the prior year.
- Non-Current Deferred Tax Liability improved to $16.8 million in Q2 2026 per RGEN's latest filing, from $15.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $39.3 million in Q4 2023 and bottomed at $14.5 million in Q3 2023.
- Historically, Non-Current Deferred Tax Liability has averaged $24.6 million across 5 years, with a median of $23.2 million in 2022.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 131.93% in 2024 and fell as far as 42.08% in 2024.
- Repligen's Non-Current Deferred Tax Liability stood at $23.0 million in 2022, then jumped by 70.97% to $39.3 million in 2023, then plunged by 42.08% to $22.8 million in 2024, then slipped by 1.23% to $22.5 million in 2025, then fell by 25.42% to $16.8 million in 2026.
- Business Quant data shows RGEN's Non-Current Deferred Tax Liability at $16.8 million in Q2 2026, $15.0 million in Q1 2026, and $22.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.78 Mn |
| Jun 30, 2026 | 16.78 Mn |
| Mar 31, 2026 | 15.02 Mn |
| Mar 31, 2026 | 15.02 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 36.81 Mn |
| Mar 31, 2024 | 36.81 Mn |